Megan Baierlein
Senior Vice President and Chief Operating Officer at Audentes Therapeutics - San Francisco, California, US
Megan Baierlein's Colleagues at Audentes Therapeutics
Megan Baierlein's Contact Details
(415) 818-1005
Audentes Therapeutics
Megan Baierlein's Company Details
Audentes Therapeutics is a leading AAV-based genetic medicines company focused on developing and commercializing innovative products for serious rare neuromuscular diseases. We are leveraging our AAV gene therapy technology platform and proprietary manufacturing expertise to develop programs across three modalities: gene replacement, vectorized exon skipping, and vectorized RNA knockdown. Our product candidates are showing promising therapeutic profiles in clinical and preclinical studies across a range of neuromuscular diseases. Audentes is a focused, experienced and passionate team driven by the goal of improving the lives of patients. If you are interested in learning more about our company, please do not hesitate to contact us.